Beijing Bausch & Lomb Stops Selling ReNu Contact Lens Solution
April 14, 2006 |
Print
|
Email
|
Comments | Category: News
Beijing Bausch & Lomb has decided to stop selling the ReNu contact lens solution that is possibly causing a rash of cornea infections around the world.
China's State Food and Medicine Supervision Bureau and Beijing Bausch & Lomb say that customers who have already purchased the contact lens solution can change the goods at Beijing Bausch & Lomb Ltd.
On February 17, the Office of Health in Singapore released news that there were more cornea inflammation cases this year compared with the same period last year, and this situation is more serious with patients who had used ReNu contact lens solution.
Although there is no clear scientific proof showing that the increase of cases is related to the ReNu solution, Bausch & Lomb has stopped sales to show its responsibility for its customers.
Leave A Comment:
-
Education
- HTC Chairman Sets Up New Charitable Foundation
- American Medical Company Plans Physician Training With New Beijing Outpost
- Chinese Universities Sign Education Deals With Christian American School
- New "100,000 Strong Initiative" Hopes To Build U.S.-China Golden Bridges
- Best Buy Creates Education Fund In China
-
Energy & Cleantech
-
Environment
-
Giving
-
Happenings
-
Health
- Legal Action Against Counterfeit Cigarettes In America Could Impact Chinese Makers
- New Collaboration In China Aims To Provide Low-cost Medicines
- Carrefour's Beijing Stores Gain Green Market Certification
- American Medical Company Plans Physician Training With New Beijing Outpost
- New Healthcare Chief Named For GE China
-
Labor
-
Law & Order
-
Viewpoints
- Companies Can Help In The March Towards Better Consumer Rights In China
- CSR Review: Companies Have More Opportunities To Develop In China
- How Far Can Chinese Companies Take Corporate Social Responsibility?
- CSR Review: Companies Focus On Sustainability In China During Downturn
- Global Financial Woes May Impact Corporate Social Responsibility In China









